Lungs
01 Jan 2013
A safety and efficacy trial evaluating the use of SanOrg34006 compared to placebo in patients who have completed 6 months of treatment for symptomatic pulmonary embolism or deep vein thrombosis
Patients diagnosed with pulmonary embolism (blood clot in the lung) or deep vein thrombosis (blood clot in a leg vein) are at risk for these blood clots to reoccur. Anticoagulant (blood-thinning) drugs are normally given immediately after the clot is discovered and are continued for a period of 3 or…
Lungs
01 Jan 2013
A safety and efficacy trial evaluating the use of SanOrg34006 in the treatment of pulmonary embolism
Patients who have a pulmonary embolism (blood clot in the lung) will be treated in this study. The purpose of the study is to compare the safety and effectiveness of a new injectable anticoagulant (blood-thinning) drug, SanOrg34006, with the standard way of treating a pulmonary embolism. The standard treatment includes…
Infections
01 Jan 2013
Efficacy and Safety of Nasonex vs. Placebo in Subjects with SAR and Concomitant Asthma
An association between seasonal allergic rhinitis (SAR) and allergic asthma has been established through epidemiologic, pathophysiologic, and therapeutic studies. This study will compare Nasonex Nasal Spray to Placebo in treating the nasal and asthma symptoms experienced by subjects with SAR and concomitant asthma. Official Title Conditions – Rhinitis, Allergic, Seasonal-…
Lungs
01 Jan 2013
A study using an investigational new medicine looking at its effects on pulmonary function and respiratory symptoms in patients with chronic obstructive pulmonary disease (COPD)
Treatment with an investigational new medicine to determine if it improves lung function and decreases the symptoms of patients with chronic obstructive pulmonary disease (COPD) Official Title Conditions – Chronic Obstructive Pulmonary Disease Study Type Interventional Study Design Treatment Further Details Study Start Eligibility & Criteria Ages Eligible…
Lungs
01 Jan 2013
Respiratory Syncytial Virus (RSV) Bronchiolitis Study
The purpose of this study is to look at whether an investigational drug can treat the breathing symptoms of RSV bronchiolitis in children 6 to 18 months of age. Official Title Conditions – Bronchiolitis Study Type Interventional Study Design Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study…
Infections
01 Jan 2013
Vitamin A Therapy for Tuberculosis
The study will determine whether a daily vitamin and mineral supplement (a multivitamin including Vitamin A) will improve health when added to standard chemotherapy for tuberculosis. This study will compare the effectiveness of the multivitamin in HIV infected and HIV uninfected patients. Official Title Adjunct Vitamin A Therapy for Tuberculosis…
Lungs
01 Jan 2013
Inhaled NO in Prevention of Chronic Lung Disease
Purpose To test the hypothesis that low-dose inhaled nitric oxide administered to preterm infants who continue to require mechanical ventilation at 14 days of age will reduce the incidence of chronic lung disease. Purpose To test the hypothesis that low-dose inhaled nitric oxide administered to preterm infants who continue…
Blood
01 Jan 2013
BEAM Trial
Purpose As many more premature infants survive, the numbers of these infants with health problems also has increased. The rate of cerebral palsy in extremely premature infants is approximately 20%. Magnesium sulfate, the most commonly used drug in the US used to stop premature labor may prevent CP. This…
Lungs
01 Jan 2013
Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients
Purpose The primary objective of this study is to evaluate the effect of Beclomethasone dipropionate HFA on small airways compared to Fluticasone propionate powder for inhalation administered twice daily to poorly controlled asthmatics. Purpose The primary objective of this study is to evaluate the effect of Beclomethasone dipropionate HFA…
